Aspheric Micro-monovision LASIK in Correction of Presbyopia and Myopic Astigmatism: Early Clinical Outcomes in a Chinese Population

老花眼 屈光度 医学 激光手术 眼科 验光服务 视力 散光 对比度(视觉) 正视 折射误差 光学 物理
作者
Ting Zhang,Yuan Sun,Shengbei Weng,Manli Liu,Yugui Zhou,Xiaonan Yang,Aleksandar Stojanović,Quan Liu
出处
期刊:Journal of Refractive Surgery [SLACK, Inc.]
卷期号:32 (10): 680-685 被引量:20
标识
DOI:10.3928/1081597x-20160628-01
摘要

To analyze early clinical outcomes of aspheric micro-monovision LASIK for correction of presbyopia and myopia with or without astigmatism.Prospective, non-comparative case series of 80 eyes of 40 patients with a mean age of 43.4 ± 4.9 years (range: 38 to 63 years) treated bilaterally using an aspheric micro-monovision protocol. The target refraction was plano for the distance eye and between -0.75 and -2.25 diopters (D) for the near eye. Visual acuity, ocular aberrations, contrast sensitivity, corneal topography, amplitude of accommodation, binocular sensorial function, and satisfaction score questionnaires were evaluated at 3 months after surgery.Three months after surgery, the mean spherical equivalent (SE) refraction in the distance eye was -0.08 ± 0.27 D, whereas the attempted and achieved SE in the near eye were -1.41 ± 0.28 and -1.32 ± 0.35 D, respectively. Ninety-three percent of eyes were within ±0.50 D of target correction of SE. The uncorrected distance visual acuity (UDVA) after surgery was -0.10 ± 0.06 logMAR (20/15.5), 0.22 ± 0.12 logMAR (20/34), and -0.11 ± 0.06 logMAR (20/15), for distance eyes, near eyes, and binocularly, respectively. Ninety-five percent of patients achieved simultaneously uncorrected distance visual acuity 0.0 logMAR (20/20) or better and uncorrected near visual acuity J2 (20/25) or better. Stability was achieved from 1 week of follow-up. The overall satisfaction score for surgery was 92 ± 6.The aspheric micro-monovision protocol provided a well-tolerated and effective means for treating myopic astigmatism and alleviating presbyopic symptoms simultaneously. [J Refract Surg. 2016;32(10):680-685.].
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
北风完成签到,获得积分10
刚刚
1秒前
1秒前
一一应助科研通管家采纳,获得10
2秒前
搜集达人应助科研通管家采纳,获得10
2秒前
Jasper应助科研通管家采纳,获得10
2秒前
研友_VZG7GZ应助方意采纳,获得10
2秒前
桐桐应助科研通管家采纳,获得10
2秒前
我是老大应助科研通管家采纳,获得10
2秒前
浮游应助科研通管家采纳,获得10
2秒前
酒剑仙完成签到,获得积分10
2秒前
浮游应助科研通管家采纳,获得10
2秒前
xxfsx应助科研通管家采纳,获得10
3秒前
Ari_Kun完成签到,获得积分10
3秒前
大模型应助科研通管家采纳,获得10
3秒前
sevenhill应助科研通管家采纳,获得10
3秒前
3秒前
赘婿应助科研通管家采纳,获得10
3秒前
CipherSage应助科研通管家采纳,获得10
3秒前
华仔应助科研通管家采纳,获得10
3秒前
浮游应助科研通管家采纳,获得10
3秒前
传奇3应助科研通管家采纳,获得10
3秒前
xxfsx应助科研通管家采纳,获得10
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
Lucas应助科研通管家采纳,获得10
4秒前
CipherSage应助科研通管家采纳,获得30
4秒前
小蘑菇应助科研通管家采纳,获得10
4秒前
pluto应助科研通管家采纳,获得10
4秒前
浮游应助科研通管家采纳,获得10
4秒前
星辰大海应助酱子采纳,获得10
4秒前
4秒前
4秒前
斧王应助儒雅的山河采纳,获得10
4秒前
4秒前
小兔子乖乖完成签到 ,获得积分10
5秒前
lucas发布了新的文献求助10
5秒前
Ava应助yang采纳,获得10
6秒前
6秒前
einsmay完成签到 ,获得积分10
6秒前
开放念云发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
Active-site design in Cu-SSZ-13 curbs toxic hydrogen cyanide emissions 500
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5462397
求助须知:如何正确求助?哪些是违规求助? 4567107
关于积分的说明 14308810
捐赠科研通 4492907
什么是DOI,文献DOI怎么找? 2461315
邀请新用户注册赠送积分活动 1450358
关于科研通互助平台的介绍 1425794